Revvity - 41 Year Stock Price History | RVTY
- The all-time high Revvity stock closing price was 199.95 on December 31, 2021.
- The Revvity 52-week high stock price is 132.54, which is 30.6% above the current share price.
- The Revvity 52-week low stock price is 79.50, which is 21.7% below the current share price.
- The average Revvity stock price for the last 52 weeks is 108.50.
Revvity Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2024 | 105.5213 | 110.2794 | 111.5277 | 99.3800 | 101.5100 | -7.01% |
2023 | 116.7753 | 140.6242 | 143.9280 | 81.9681 | 109.1609 | -21.86% |
2022 | 149.9409 | 191.1403 | 191.1403 | 116.5176 | 139.7075 | -30.13% |
2021 | 158.3444 | 144.4420 | 199.9515 | 119.5222 | 199.9515 | 40.37% |
2020 | 106.3677 | 97.8640 | 146.8244 | 66.0836 | 142.4468 | 48.19% |
2019 | 88.9589 | 75.9052 | 99.8688 | 71.8297 | 96.1217 | 24.01% |
2018 | 79.4788 | 72.6796 | 95.9103 | 70.9219 | 77.5137 | 7.80% |
2017 | 62.7447 | 51.8718 | 72.6107 | 50.5491 | 71.9027 | 40.85% |
2016 | 50.6412 | 51.0449 | 55.6452 | 40.4150 | 51.0495 | -2.12% |
2015 | 48.3708 | 42.6768 | 52.9239 | 41.2926 | 52.1548 | 23.21% |
2014 | 42.8162 | 39.3715 | 46.5508 | 38.4857 | 42.3283 | 6.75% |
2013 | 33.8600 | 30.6111 | 39.7657 | 29.0704 | 39.6503 | 30.96% |
2012 | 26.0218 | 19.4409 | 30.8018 | 19.2238 | 30.2772 | 60.41% |
2011 | 22.3503 | 24.1557 | 26.6880 | 16.5059 | 18.8746 | -21.62% |
2010 | 20.9570 | 19.0021 | 24.3796 | 17.5646 | 24.0811 | 27.04% |
2009 | 15.3143 | 12.8165 | 19.2569 | 10.0002 | 18.9560 | 50.67% |
2008 | 21.8850 | 22.8275 | 26.7627 | 11.8848 | 12.5813 | -45.92% |
2007 | 23.1425 | 19.3597 | 26.6346 | 18.9264 | 23.2656 | 18.34% |
2006 | 18.6865 | 20.9428 | 21.0855 | 15.7664 | 19.6604 | -4.41% |
2005 | 18.2165 | 19.0245 | 20.8293 | 15.6191 | 20.5674 | 6.19% |
2004 | 16.6385 | 14.8838 | 19.7135 | 13.5019 | 19.3690 | 33.79% |
2003 | 10.9545 | 7.3054 | 15.8337 | 6.1801 | 14.4767 | 112.10% |
2002 | 10.4387 | 28.0684 | 29.0550 | 3.6155 | 6.8255 | -75.70% |
2001 | 25.8258 | 38.5783 | 39.8112 | 17.0280 | 28.0924 | -32.73% |
2000 | 29.7594 | 16.3324 | 47.5269 | 15.3707 | 41.7600 | 154.16% |
1999 | 13.0059 | 11.1552 | 17.2665 | 10.0216 | 16.4309 | 52.59% |
1998 | 10.3146 | 7.9044 | 12.8993 | 7.4539 | 10.7680 | 36.69% |
1997 | 7.6950 | 7.3242 | 8.9481 | 6.7704 | 7.8779 | 6.28% |
1996 | 7.4800 | 8.5562 | 8.9267 | 6.0310 | 7.4126 | -14.69% |
1995 | 6.1352 | 5.0585 | 8.6888 | 4.6312 | 8.6888 | 77.85% |
1994 | 5.4571 | 5.9333 | 6.3998 | 4.7997 | 4.8855 | -20.48% |
1993 | 6.7725 | 6.4763 | 8.0359 | 5.3492 | 6.1438 | -3.88% |
1992 | 7.3779 | 7.7186 | 8.5127 | 5.9030 | 6.3916 | -19.47% |
1991 | 6.4388 | 4.9362 | 7.9372 | 4.8988 | 7.9372 | 64.01% |
1990 | 5.6089 | 5.2509 | 6.3132 | 4.3711 | 4.8394 | -6.48% |
1989 | 4.9155 | 4.2656 | 5.5370 | 4.2656 | 5.1748 | 20.77% |
1988 | 4.8101 | 4.9409 | 5.6447 | 4.0614 | 4.2850 | -11.97% |
1987 | 5.1376 | 4.1185 | 6.5240 | 4.1185 | 4.8677 | 18.19% |
1986 | 4.9634 | 5.5764 | 6.2135 | 4.0821 | 4.1185 | -26.39% |
1985 | 5.4762 | 4.5923 | 6.1960 | 4.5923 | 5.5954 | 21.38% |
1984 | 4.4850 | 4.7017 | 5.1930 | 3.8634 | 4.6098 | -2.71% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $12.539B | $2.751B |
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $124.869B | 15.67 |
Cencora (COR) | United States | $48.051B | 19.18 |
ICON (ICLR) | Ireland | $25.434B | 24.01 |
DiDi Global (DIDIY) | China | $24.387B | 0.00 |
Avantor (AVTR) | United States | $16.238B | 23.94 |
Viatris (VTRS) | United States | $13.880B | 3.96 |
CochLear (CHEOY) | $13.776B | 0.00 | |
Medpace Holdings (MEDP) | United States | $12.267B | 40.36 |
Charles River Laboratories (CRL) | United States | $11.798B | 21.51 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $11.548B | 0.00 |
Natera (NTRA) | United States | $11.205B | 0.00 |
Solventum (SOLV) | United States | $11.115B | 0.00 |
HealthEquity (HQY) | United States | $6.886B | 51.45 |
Bausch + Lomb (BLCO) | Canada | $5.197B | 19.99 |
Organon (OGN) | United States | $4.742B | 4.59 |
Doximity (DOCS) | United States | $4.444B | 33.08 |
PACS (PACS) | United States | $3.713B | 0.00 |
Sotera Health (SHC) | United States | $3.227B | 15.83 |
Surgery Partners (SGRY) | United States | $3.108B | 28.88 |
Progyny (PGNY) | United States | $3.079B | 51.68 |
GoodRx Holdings (GDRX) | United States | $2.840B | 143.80 |
Life Times (LTH) | United States | $2.783B | 30.76 |
Premier (PINC) | United States | $2.511B | 9.19 |
Teladoc Health (TDOC) | United States | $2.203B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $2.164B | 7.00 |
Agilon Health (AGL) | United States | $2.055B | 0.00 |
BrightSpring Health Services (BTSG) | United States | $1.811B | 0.00 |
Agiliti (AGTI) | United States | $1.368B | 22.33 |
NovoCure (NVCR) | Jersey | $1.360B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.331B | 0.00 | |
Alignment Healthcare (ALHC) | United States | $0.985B | 0.00 |
Pediatrix Medical (MD) | United States | $0.760B | 7.86 |
Embecta (EMBC) | United States | $0.594B | 3.92 |
InnovAge Holding (INNV) | United States | $0.531B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.522B | 0.00 |
Enhabit (EHAB) | United States | $0.503B | 45.59 |
COMPASS Pathways (CMPS) | United Kingdom | $0.492B | 0.00 |
LifeMD (LFMD) | United States | $0.482B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.434B | 0.00 |
Beauty Health (SKIN) | United States | $0.400B | 0.00 |
CareDx (CDNA) | United States | $0.391B | 0.00 |
DocGo (DCGO) | United States | $0.376B | 60.17 |
MultiPlan (MPLN) | United States | $0.371B | 0.00 |
Sera Prognostics (SERA) | United States | $0.349B | 0.00 |
ModivCare (MODV) | United States | $0.335B | 4.44 |
Sharecare (SHCR) | United States | $0.290B | 0.00 |
GeneDx Holdings (WGS) | United States | $0.289B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.269B | 0.00 |
Biodesix (BDSX) | United States | $0.142B | 0.00 |
So-Young (SY) | China | $0.125B | 41.83 |
Oncology Institute (TOI) | United States | $0.085B | 0.00 |
Pono Capital Two (PTWO) | United States | $0.078B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
NeueHealth (NEUE) | United States | $0.050B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.035B | 0.00 |
Nutex Health (NUTX) | United States | $0.033B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.024B | 0.00 |
DermTech (DMTK) | United States | $0.021B | 0.00 |
OncoCyte (OCX) | United States | $0.021B | 0.00 |
BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
XWELL (XWEL) | United States | $0.008B | 0.00 |
NewGenIvf Group (NIVF) | Singapore | $0.007B | 0.00 |
OpGen (OPGN) | United States | $0.007B | 0.00 |
Assure Holdings (IONM) | United States | $0.005B | 0.00 |
ISpecimen (ISPC) | United States | $0.002B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |